Mitsubishi UFJ Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.8M Buy
1,002,472
+141,143
+16% +$2.37M 0.01% 516
2025
Q1
$13.2M Buy
861,329
+53,443
+7% +$821K 0.01% 544
2024
Q4
$17.2M Buy
807,886
+70,978
+10% +$1.51M 0.02% 508
2024
Q3
$13.3M Buy
736,908
+43,228
+6% +$779K 0.01% 533
2024
Q2
$11.3M Buy
693,680
+65,989
+11% +$1.07M 0.01% 533
2024
Q1
$8.86M Buy
627,691
+167,097
+36% +$2.36M 0.01% 550
2023
Q4
$5.04M Hold
460,594
0.01% 602
2023
Q3
$4.7M Hold
460,594
0.01% 608
2023
Q2
$3.47M Buy
460,594
+76,684
+20% +$577K 0.01% 660
2023
Q1
$3.4M Buy
383,910
+43,245
+13% +$383K 0.01% 644
2022
Q4
$3.25M Hold
340,665
0.01% 633
2022
Q3
$2.75M Buy
340,665
+45,149
+15% +$364K 0.01% 651
2022
Q2
$2.22M Buy
295,516
+43,987
+17% +$331K 0.01% 686
2022
Q1
$2.36M Sell
251,529
-6,866
-3% -$64.5K 0.01% 702
2021
Q4
$2.15M Buy
258,395
+9,759
+4% +$81.3K 0.01% 740
2021
Q3
$2.42M Hold
248,636
0.01% 708
2021
Q2
$2.46M Buy
248,636
+24,844
+11% +$246K 0.01% 707
2021
Q1
$2.58M Buy
223,792
+12,004
+6% +$139K 0.02% 649
2020
Q4
$2.04M Buy
211,788
+10,330
+5% +$99.7K 0.02% 652
2020
Q3
$1.82M Buy
201,458
+26,083
+15% +$235K 0.02% 604
2020
Q2
$2.16M Buy
175,375
+12,586
+8% +$155K 0.02% 522
2020
Q1
$1.46M Sell
162,789
-4,541
-3% -$40.8K 0.02% 539
2019
Q4
$1.52M Buy
167,330
+18,793
+13% +$171K 0.02% 607
2019
Q3
$1.02M Sell
148,537
-1,796
-1% -$12.4K 0.02% 617
2019
Q2
$1.39M Buy
150,333
+31,894
+27% +$294K 0.02% 551
2019
Q1
$1.86M Buy
118,439
+9,876
+9% +$155K 0.04% 423
2018
Q4
$1.79M Sell
108,563
-13,732
-11% -$226K 0.05% 368
2018
Q3
$2.63M Buy
122,295
+9,490
+8% +$204K 0.05% 336
2018
Q2
$2.74M Buy
112,805
+3,331
+3% +$81K 0.06% 314
2018
Q1
$1.87M Sell
109,474
-11,864
-10% -$203K 0.04% 410
2017
Q4
$2.32M Sell
121,338
-6,162
-5% -$118K 0.05% 371
2017
Q3
$2.24M Buy
127,500
+7,800
+7% +$137K 0.05% 355
2017
Q2
$3.98M Sell
119,700
-16,816
-12% -$559K 0.1% 213
2017
Q1
$4.38M Buy
136,516
+1,562
+1% +$50.1K 0.1% 212
2016
Q4
$5.06M Buy
+134,954
New +$5.06M 0.12% 172